SEC Filings for Inovio Pharmaceuticals Inc. (INO)

$ 8.12   -0.20 (-2.40%) Volume: 11.63m 4:00 PM EDT Apr 9, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)304/06/2020
8-KCurrent report pursuant to Section 13 or 15(d)2304/03/2020
424B5Prospectus [Rule 424(b)(5)]5104/03/2020
DEF 14AOther definitive proxy statements4003/27/2020
4Statement of changes in beneficial ownership of securities103/26/2020
4Statement of changes in beneficial ownership of securities103/23/2020
S-3Registration statement under Securities Act of 193314503/13/2020
4Statement of changes in beneficial ownership of securities103/12/2020
4Statement of changes in beneficial ownership of securities103/12/2020
4Statement of changes in beneficial ownership of securities103/12/2020
10-KAnnual report pursuant to Section 13 or 15(d)15003/12/2020
4Statement of changes in beneficial ownership of securities103/12/2020
4Statement of changes in beneficial ownership of securities103/12/2020
4Statement of changes in beneficial ownership of securities103/09/2020
<<
First
<
Prev
123456789101112131415